PV Bulletin

Qu Feng Huo Lou Dan May Be Harmful Due to Hidden Ingredient

The FDA advises against the purchase or use of Qu Feng Huo Lou Dan due to harmful hidden ingredient.

Primary source: form

PV Impact Brief

Urgency: HighConfidence: high

What changed

The FDA has issued a consumer advisory against the use of Qu Feng Huo Lou Dan, indicating it contains dexamethasone, a steroid that can harm users.

Why it matters

This warning is crucial as dexamethasone can weaken the immune system and lead to severe withdrawal symptoms; immediate action is advised for users.

Action needed

Consumers should consult healthcare professionals if using this product and report any adverse effects to FDA’s MedWatch Safety Information.

Relevant for
QPPVSignal Management LeadMedical Safety Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 25, 2026

Full briefing

Practical implication

Consumers should consult healthcare professionals if using this product and report any adverse effects to FDA’s MedWatch Safety Information.

The FDA warns that Qu Feng Huo Lou Dan, promoted for pain relief, may contain dexamethasone not listed on the label, posing health risks.

What changed: The FDA has issued a consumer advisory against the use of Qu Feng Huo Lou Dan, indicating it contains dexamethasone, a steroid that can harm users.

Why it matters: This warning is crucial as dexamethasone can weaken the immune system and lead to severe withdrawal symptoms; immediate action is advised for users.

Practical implication: Consumers should consult healthcare professionals if using this product and report any adverse effects to FDA’s MedWatch Safety Information.

View original source

  • Source: FDA - What's New Drugs RSS
  • Published at source: 2026-08-25T00:00:00.000Z
  • Discovered by monitor: 2026-08-25T19:36:40.064Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signal#Safety Signals#Source-ingestion#Regulator-monitor#Usa#Fda.gov

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Atellica CH Revised C-Reactive Protein (RCRP) Safety Information - Siemens Healthcare Diagnostics

Urgency: High

Laboratories must implement the safety measures as indicated by the action registration number R2625739, effective from the notice date of September 7, 2026.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward